← Holders
Parkman Healthcare Partners LLC
What Parkman Healthcare Partners LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.
CIK 1777015 · Filed Nov 16, 2026
- Positions
- 91
- Reported value
- $1.1B
- Opened
- 27
- Closed
- 13
- Other managers included
- 0
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
Quarters on file
- Sep 30, 2025$958.7M91 positions
- Dec 31, 2025$1.1B100 positions
- Mar 31, 2026$969.6M90 positions
- Jun 30, 2026$976.8M77 positions
- Sep 30, 2026$1.1B91 positions
| Security | Shares | Change | Value | Of portfolio |
|---|---|---|---|---|
PTCTPTC Therapeutics, Inc. | 700.4K | +60.8% | $45.4M | 4.1% |
LLYEli Lilly & Co | 38.1K | +8.9% | $44.1M | 4% |
MBXMBX Biosciences, Inc. | 716.5K | −10.5% | $42M | 3.8% |
IQVIQVIA Holdings Inc. | 145.2K | +37.2% | $39M | 3.5% |
DXCMDexCom Inc | 437K | −18.3% | $37.7M | 3.4% |
INBXInhibrx Biosciences, Inc. | 360.3K | +40.2% | $36.1M | 3.2% |
VRDNViridian Therapeutics, Inc. | 1.7M | +21.6% | $34.5M | 3.1% |
URGNUroGen Pharma Ltd. | 750.2K | +331.0% | $30.5M | 2.7% |
SRRKScholar Rock Holding Corp | 540K | New | $26.1M | 2.4% |
CVSCVS Health Corp | 286.3K | −26.9% | $24.5M | 2.2% |
ANROAlto Neuroscience, Inc. | 948.9K | +121.2% | $24.2M | 2.2% |
AGIOAgios Pharmaceuticals, Inc. | 633.3K | −5.3% | $21.1M | 1.9% |
SNDXSyndax Pharmaceuticals Inc | 1.1M | +26.0% | $20.8M | 1.9% |
UNHUnitedHealth Group Inc | 55.9K | −0.1% | $20.5M | 1.8% |
AMLXAmylyx Pharmaceuticals, Inc. | 675.1K | +69.3% | $19.6M | 1.8% |
ASMBAssembly Biosciences, Inc. | 796.3K | +10.4% | $18.7M | 1.7% |
INDVSupernus, Inc. | 521.6K | +43.2% | $18.7M | 1.7% |
CRLCharles River Laboratories International, Inc. | 60K | New | $17.7M | 1.6% |
KODKodiak Sciences Inc. | 186K | New | $17.6M | 1.6% |
RCUSArcus Biosciences, Inc. | 675.5K | −26.5% | $17.4M | 1.6% |
ADPTAdaptive Biotechnologies Corp | 600.1K | +23.2% | $17.3M | 1.6% |
TARSTarsus Pharmaceuticals, Inc. | 213.4K | +42.3% | $16.8M | 1.5% |
ABTAbbott Laboratories | 165.2K | New | $16.3M | 1.5% |
THCTenet Healthcare Corp | 63.9K | −34.4% | $16.3M | 1.5% |
XERSXeris Biopharma Holdings, Inc. | 1.6M | −9.1% | $15.7M | 1.4% |
LIVNLivaNova PLC | 195.6K | −7.1% | $15M | 1.3% |
WSTWest Pharmaceutical Services Inc | 40K | New | $14.8M | 1.3% |
AVTXAvalo Therapeutics, Inc. | 929.4K | +21.3% | $14.2M | 1.3% |
AVAHAveanna Healthcare Holdings, Inc. | 1.1M | +57.7% | $14M | 1.3% |
SIShoulder Innovations, Inc. | 726.9K | +221.3% | $13.7M | 1.2% |
ANIPANI Pharmaceuticals Inc | 185.9K | −8.4% | $13.5M | 1.2% |
EWTXEdgewise Therapeutics, Inc. | 328K | −43.2% | $13.3M | 1.2% |
CSTLCastle Biosciences Inc | 367.9K | +154.1% | $13.1M | 1.2% |
CDNACareDx, Inc. | 200.4K | −1.0% | $13M | 1.2% |
ATRCAtriCure, Inc. | 225.2K | New | $12.7M | 1.1% |
WATWaters Corp | 27.9K | −7.7% | $12.2M | 1.1% |
INSMInsmed Inc | 105.1K | New | $12M | 1.1% |
CYRXCryoport, Inc. | 678.6K | +33.5% | $11.8M | 1.1% |
SDGRSchrodinger, Inc. | 375K | New | $11.6M | 1% |
JAZZJazz Pharmaceuticals plc | 50.1K | New | $11.6M | 1% |
FDMT4D Molecular Therapeutics, Inc. | 772.2K | −18.6% | $11M | 1% |
CARLCarlsmed, Inc. | 779.8K | +30.5% | $11M | 1% |
COAGHemab Therapeutics Holdings, Inc. | 329.3K | +631.7% | $10.2M | 0.9% |
IRTCiRhythm Holdings, Inc. | 85.7K | +27.5% | $9.7M | 0.9% |
INSPInspire Medical Systems, Inc. | 130K | New | $9M | 0.8% |
TEMTempus AI, Inc. | 110K | New | $9M | 0.8% |
NVCTNuvectis Pharma, Inc. | 425.4K | New | $9M | 0.8% |
GPCRStructure Therapeutics Inc. | 283.8K | −41.6% | $8.9M | 0.8% |
COGTCogent Biosciences, Inc. | 275.8K | +8.9% | $8.8M | 0.8% |
ALNYAlnylam Pharmaceuticals, Inc. | 35.2K | −30.6% | $8.7M | 0.8% |
SUPNSupernus, Inc. | 200K | New | $8.6M | 0.8% |
IMNMImmunome Inc. | 396.4K | −33.3% | $8.5M | 0.8% |
MLYSMineralys Therapeutics, Inc. | 314K | −17.4% | $7.9M | 0.7% |
VTRSViatris Inc | 443.1K | +121.6% | $7.9M | 0.7% |
PODDInsulet Corp | 59.9K | −54.4% | $7.8M | 0.7% |
XENEXenon Pharmaceuticals Inc. | 208.1K | −47.6% | $7.7M | 0.7% |
XGNExagen Inc. | 926.5K | New | $7.5M | 0.7% |
TFXTeleflex Inc | 60K | New | $7.5M | 0.7% |
SIBNSi-Bone, Inc. | 392.8K | +19.5% | $7.4M | 0.7% |
DRUGBright Minds Biosciences Inc. | 148.2K | −27.7% | $7.4M | 0.7% |
VCELVericel Corp | 180.2K | New | $7.2M | 0.7% |
STOKStoke Therapeutics, Inc. | 267K | −24.9% | $6.9M | 0.6% |
NVSTEnvista Holdings Corp | 281K | −49.3% | $6.6M | 0.6% |
MMEDMiniMed Group, Inc. | 321.5K | +42.0% | $6.3M | 0.6% |
VIRVir Biotechnology, Inc. | 517.4K | +8.9% | $5.8M | 0.5% |
CLYMClimb Bio, Inc. | 468.2K | −16.9% | $5.4M | 0.5% |
DTILPrecision Biosciences Inc | 836.8K | New | $5.2M | 0.5% |
ABSIAbsci Corp | 478.7K | −46.5% | $5.2M | 0.5% |
ORKAOruka Therapeutics, Inc. | 53.2K | −53.0% | $4.4M | 0.4% |
RCELAVITA Medical, Inc. | 350.6K | New | $4.1M | 0.4% |
OABIOmniAb, Inc. | 726.2K | New | $3.6M | 0.3% |
ERASErasca, Inc. | 231.5K | −10.5% | $3.4M | 0.3% |
UPBUpstream Bio, Inc. | 618.1K | −33.9% | $3.3M | 0.3% |
OPRXOptimizeRx Corp | 381.4K | +8.9% | $3.2M | 0.3% |
ATECAlphatec Holdings, Inc. | 289.4K | −35.7% | $3M | 0.3% |
KIDSOrthopediatrics Corp | 125.2K | New | $2.8M | 0.3% |
IVAInventiva S.A. | 651.1K | New | $2.4M | 0.2% |
AORTArtivion, Inc. | 101.3K | −27.1% | $2.3M | 0.2% |
APMDApnimed, Inc. | 105.3K | New | $2.3M | 0.2% |
IRONDisc Medicine, Inc. | 35K | New | $2.3M | 0.2% |
FOCLEdap TMS SA | 491.6K | +217.5% | $2.2M | 0.2% |
ANNXAnnexon, Inc. | 497.7K | −22.4% | $2.1M | 0.2% |
ALGSAligos Therapeutics, Inc. | 325.5K | New | $1.8M | 0.2% |
LUNGPulmonx Corp | 854K | +32.1% | $1.6M | 0.1% |
NSPRInspireMD, Inc. | 2.4M | ±0% | $1.6M | 0.1% |
EYPTEyePoint, Inc. | 486.4K | −62.2% | $1.6M | 0.1% |
LMRILumexa Imaging Holdings, Inc. | 140.4K | New | $1.4M | 0.1% |
LQDALiquidia Corp | 35K | New | $1.1M | 0.1% |
ENTXEntera Bio Ltd. | 298.8K | +8.9% | $869.5K | 0.1% |
LYELLyell Immunopharma, Inc. | 85.8K | New | $839.6K | 0.1% |
OVIDOvid Therapeutics Inc. | 215.5K | +8.8% | $536.5K | 0.1% |